ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cellsStephanie A. Yazinski, Lee Zou, Michael J. Birrer et al.|Genes & Development|2017Cited by 398
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Daniel A. Haber, Irun Bhan et al.|Proceedings of the National Academy of Sciences|2017Cited by 157
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate CancerDavid T. Miyamoto, Daniel A. Haber, Richard J. Lee et al.|Cancer Discovery|2018Cited by 140
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapyXin Hong, Daniel A. Haber, Ryan J. Sullivan et al.|Proceedings of the National Academy of Sciences|2018Cited by 130
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerTanya T. Kwan, Shyamala Maheswaran, Aditya Bardia et al.|Cancer Discovery|2018Cited by 116